On January 19, 2024, New Journey Health Technology Group Co.,LTD closed the transaction. The transaction has been approved in the 16th meeting of the 6th board of directors and the 13th meeting of the 6th board of supervisors. Before the announcement of the issuance plan to specific targets, Beijing New Journey Health Industry Group Co., Ltd. held 825,927,323 shares of New Journey Health Technology Group Co., LTD and was the controlling shareholder of the listed company.

After the issuance of shares to specific targets is completed, Beijing New Journey Health Industry Group Co., Ltd. will hold 1,044,340,021 shares of New Journey Health Technology Group Co., LTD, accounting for 28.78% of the company's total share capital after the issuance.